BRIAN SCHWARTZ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BRIAN SCHWARTZ.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BRIAN SCHWARTZ. BRIAN SCHWARTZ is a Chief Medical Officer in ARQULE INC ($ARQL) and a See Remarks in ARQULE INC ($ARQL) and a Director in Cyclacel Pharmaceuticals, Inc. ($CYCC).

Address: NAVY YARD PLAZA 1 FIRST AVENUE PARISH, BUILDING #3 BOSTON 02129 MA

Companies in which BRIAN SCHWARTZ is an Insider

ARQULE INC

Trading Symbol: ARQL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BRIAN SCHWARTZ: See Remarks, Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 16 2020
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Cyclacel Pharmaceuticals, Inc.

Trading Symbol: CYCC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BRIAN SCHWARTZ: Director
Holdings: 0 shares
Latest Transaction: Dec 21 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of BRIAN SCHWARTZ

Sentiment: All, ARQL, CYCC

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 21 2020CYCCCyclacel Pharmaceu ...SCHWARTZ BRIANDirectorOption ExerciseA4.135,20021,4765,200
Dec 21 2020CYCCCyclacel Pharmaceu ...SCHWARTZ BRIANDirectorOption ExerciseA4.135,20021,4765,200
Jan 16 2020ARQLARQULE INCSCHWARTZ BRIANSee RemarksOption ExerciseD2.57106,500273,7050
Jan 16 2020ARQLARQULE INCSCHWARTZ BRIANSee RemarksOption ExerciseD2.5121,37653,6540
Jan 16 2020ARQLARQULE INCSCHWARTZ BRIANSee RemarksOption ExerciseD7.9512,57899,9950
Jan 16 2020ARQLARQULE INCSCHWARTZ BRIANSee RemarksOption ExerciseD6.70140,000938,0000
Jan 16 2020ARQLARQULE INCSCHWARTZ BRIANSee RemarksOption ExerciseD3.68314,0501,155,7040

View all BRIAN SCHWARTZ insider transactions.